NOV 09, 2017 09:00 AM PST

Monitoring Pain Management Medications in Pregnancy and the Neonate

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Medical Director, Toxicology and Pharmacogenetics, ARUP Laboratories
    Biography
      Dr. McMillin is a professor of pathology at the University of Utah School of Medicine. She received her PhD in pharmacology and toxicology from the University of Utah and is certified by the American Board of Clinical Chemistry in clinical chemistry and toxicological chemistry. Dr. McMillin is actively involved in professional associations such as the International Association of Therapeutic Drug Monitoring and Clinical Chemistry (IATDMCT), the American Association for Clinical Chemistry (AACC), and the College of American Pathologists (CAP). Her primary interests include detection of neonatal drug exposures, as well as clinical applications and implementation of pharmacogenomics.

    Abstract:

    Acute and chronic pain are often managed with drug therapy, which may include extended use of drug classes such as opioids and benzodiazepines.  Pain does not go away, and may intensify during pregnancy.  A woman who uses drugs (prescribed and/or non-prescribed) during pregnancy may expose her unborn child to compounds that could adversely affect neonatal development, may lead to premature delivery, and may precipitate a characteristic withdrawal syndrome called neonatal abstinence syndrome (NAS).  In the United States, the Centers for Disease Control and Prevention has reported that among 28 states surveyed, the overall incidence of NAS increased by 300% from 1999 to 2013 (https://www.cdc.gov/mmwr/volumes/65/wr/mm6531a2.htm).  A pregnant woman that has a known addiction to opioids may be managed with opioid substitution agents such as buprenorphine or methadone, which may reduce the incidence and severity of NAS.  Nonetheless, treatment of NAS may require several weeks of intensive care for the newborn, as well as extensive follow-up care and social management.  As such, accurate and timely detection of in utero substance exposure is a critical component of pre- and post-natal care and can assure provision of appropriate medical and social services for the newborn, the mother, and the associated caregivers.  Testing biological specimens for drugs is an important tool for detection and confirmation of drug exposure.  This presentation will describe pros and cons of several specimen types used to monitor exposure to medications during pregnancy and after delivery.  Common analytical methods and challenges with interpretation of results will also be discussed.


    Show Resources
    You May Also Like
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    APR 25, 2018 07:00 AM PDT
    C.E. CREDITS
    APR 25, 2018 07:00 AM PDT
    DATE: April 25, 2018TIME: 1500 CET, 10:00 a.m. EST, 7:00 a.m. PST Hematology and coagulation laboratories perform a wide range of routine and specialized tests, allowing clinicians to...
    Loading Comments...